FutureTox IV

Toxicological Concerns in Older Adults, a Neglected Majority

March 10, 2018 | San Antonio, Texas



The older adult population is growing faster than the total population in practically all regions of the world—and this difference in growth rates is accelerating. The proportion of older adults is projected to more than double worldwide over the next half century. At the global level, one in every 12 individuals was at least 60 years of age in 1950. By the year 2050, more than one in every five persons is projected to be aged 60 or over. Despite this increase, few issues in toxicological science associated with the aging process have been addressed. Older adults have uniquely increased susceptibilities to pharmaceuticals and environmental toxicants, but remain largely unrecognized as a sensitive or vulnerable population.

Although considerable effort has been spent addressing the biological aspects of aging, including genetics and pharmacology, toxicological effects specific to older populations have been understudied. The primary goal of this CCT meeting is to increase understanding of the changes associated with the aging process and discuss ways in which these changes may influence toxicity outcomes. The discussions will have potential impact on the development of toxicological assessments, the drug development process, and clinical practice.

This meeting will address the following:

  1. Current knowledge of the aging process and risk factors for toxicity in the older adult population;
  2. The most common toxic outcomes in older adults and the physiological systems involved;
  3. Distinct challenges associated with toxicological research and clinical trial efforts relevant to the aging population; and
  4. The need for dialogue between clinicians and toxicologists to enhance information exchange and collaboration.


Room 302


Abstracts should relate to the topics and themes for this CCT meeting, as conveyed in the Background section of this page. Accepted abstracts will be displayed for the duration of the CCT meeting with poster presentations occurring during the luncheon portion of the agenda.

Abstract submission is open to all attendees, and there is no fee associated with submission. The submission deadline is March 2, 2018.

Abstract acceptance notifications will occur in February 2018. If your abstract is accepted, please consult and follow the CCT meeting’s poster preparation and display instructions for preparing and displaying your poster.



Henry B. González
Convention Center
Room 302

San Antonio, Texas

more info

Attendees should make their hotel reservations for this event through the 2018 SOT Annual Meeting Housing System


Fees include all CCT meeting sessions, program materials, and refreshments throughout the course of the CCT meeting.

If you need special assistance for this meeting, please contact SOT Headquarters at 703.438.3115.

August 1, 2017–February 9, 2018
SOT Member
SOT Student/Postdoc Member
Student/Postdoc Nonmember

After February 9, 2018
SOT Member
SOT Student/Postdoc Member
Student/Postdoc Nonmember

Mail-in Registration

Download Form

When using the mail-in registration form, payment must be submitted in one of the following ways:

  • Check (please list all registrants on the check stub)
  • Money Order
  • Credit Card (Visa, MasterCard, Diner’s Club, or American Express)
  • US Government Purchase Order (check must be drawn from the US Department of the Treasury)
  • Wire Transfer (include an additional $40 processing fee)

Submit your completed registration via:

  • Mail:
    Toxicological Concerns in Older Adults, a Neglected Majority CCT
    Society of Toxicology
    11190 Sunrise Valley Drive, Suite 300
    Reston, VA 20191-4375
  • Fax: 703.438.3113
  • NOTE: To prevent double-billing, if you are registering by fax, DO NOT mail your original registration form. SOT needs only one copy for processing.

Registration Terms and Conditions

Registration Cancellation Refund Policy: All requests for cancellations and/or refunds must be received in writing to SOT Headquarters by February 10, 2018. These refunds will be processed, less a $30 fee, following the CCT meeting.

SOT reserves the right to review all registrations and to determine that individuals or organizations meet the Society’s criteria for participation.

For non-SOT members, participation in this CCT meeting is reserved for bona fide individuals who are engaged in or promote the field of toxicology or biotechnology research and support the growth and development of the toxicology field. In addition, participation in this CCT meeting is reserved for bona fide organizations with public policy positions and business practices that are generally consistent with SOT’s mission, goals, reputation, and its policies and principles as determined by the Society. SOT reserves the right to review registration applications for this CCT meeting to confirm that the applicant meets these criteria and may, at the Society’s sole discretion, reject a registration by an individual or business or withdraw registration privileges at any time if any individual or organization is found to be inconsistent with SOT’s principles and interests.

Show more Show less

Organizing Committee

Florence G. Burleson, PhD

Burleson Research Technologies Inc., Morrisville, NC

Kenneth L. Hastings, MPH, DrPH

Hastings Toxicology Consulting LLC, Mount Airy, MD

John DeSesso, PhD, ATS

Exponent Inc., Alexandria, VA

Rosalie Elespuru, PhD

US Food and Drug Administration, Silver Spring, MD

John “Jack” R. Fowle III, PhD, DABT

Science To Inform LLC, Pittsboro, NC

Mary Jeanne Kallman, PhD, DSP

Kallman Preclinical Consulting, Greenfield, IN

S.W. Johnny Lau, RPh, PhD, DABCP

US Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD

Donna L. Mendrick, PhD

US Food and Drug Administration, National Center for Toxicological Research, Silver Spring, MD

Sharmilee P. Sawant, PhD, DABT

Halyard Health, Alpharetta, GA

Charles E. Wood, DVM, PhD, DACVP

US Environmental Protection Agency, Research Triangle Park, NC

CCT Committee Liaison:
Alison Harrill, PhD

National Institute of Environmental Health Sciences, Durham, NC

CCT Committee Liaison:
Xi Yang, PhD

US Food and Drug Administration, Silver Spring, MD

SOT Council Contact:
Tao Wang, MD, PhD, DABT

Achaogen, South San Francisco, CA


Diamond Level

Gold Level

Silver Level

Contributor Level

Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Info


11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191-4375